The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo-Reference-Cited by-同舟云学术

The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo

Published:2023-05 Issue: Volume:165 Page:156167
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Doggett Karen,Keating Narelle,Dehkhoda Farhad,Bidgood Grace M.,Meza Guzman Lizeth G.,Leong Evelyn,Kueh Andrew,Nicola Nicos A.,Kershaw Nadia J.,Babon Jeffrey J.,Alexander Warren S.,Nicholson Sandra E.

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference38 articles.

1. Twenty proteins containing a C-terminal SOCS box form five structural classes;Hilton;Proc. Natl. Acad. Sci. USA,1998

2. A new protein containing an SH2 domain that inhibits JAK kinases;Endo;Nature,1997

3. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain;Sasaki;Genes Cells,1999

4. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins;Koch;Science,1991

5. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation;Zhang;Proc. Natl. Acad. Sci. USA,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of pro-inflammatory and pro-survival components in neuroinflammatory signalling and neurodegeneration;Ageing Research Reviews;2024-09

2. Transcriptional and methylation outcomes of didehydro-cortistatin A use in HIV-1–infected CD4⁺T cells;Life Science Alliance;2024-08-01

3. Genome-wide identification and characterization of large yellow croaker (Larimichthys crocea) suppressors of cytokine signaling (SOCS) in immune response to Pseudomonas plecoglossicida infection and acute hypoxia stress;Fish & Shellfish Immunology;2024-08

4. Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress;Frontiers in Immunology;2024-07-22

5. SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity;Frontiers in Immunology;2024-06-14